The carbohydrate-deficient transferrin as a marker of chronic alcohol consumption and assessment of its usefulness in patients with cardiovascular diseases – a pilot study
By:
References
- O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, et al. INTERSTROKE investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016; 388: 761–775.
- World Health Organization. 2018. Global status report on alcohol and health 2018.
- Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet. 2007; 370: 1089–1100.
- Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R. Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med. 2007; 69: 323–331.
- Rosengren A, Tibblin G, Wilhelmsen L. Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men. J Am Cardiol. 1991; 68: 1171–1175.
- Leong DP, Smyth A, Teo KK, McKee M, Rangarajan S, Pais P, Liu L, Anand SS, Yusuf S. INTERHEART Investigators. Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case-control study. Circulation. 2014; 130: 390–398.
- Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, Paige E, Paul DS, Sweeting M, Burgess S, et al. Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018; 391: 1513–1523.
- Britton A, McKee M. The relation between alcohol and cardiovascular disease in Eastern Europe: explaining the paradox. J Epidemiol Community Health. 2000; 54: 328–332.
- Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction. 2000; 95: 1505–1523.
- Einvik G, Ekeberg Ø, Klemsdal TO, Sandvik L, Hjerkinn EM. Physical distress is associated with cardiovascular events in a high risk population of elderly men. BMC Cardiovasc Disorders. 2009; 9: 14.
- Miller PM, Anton RF. Biochemical alcohol screening in primary health care. Addict Behav. 2004; 29: 1427–1437.
- Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010; 56: 38–46.
- ESC/EASD Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases, 2019. Available at: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Diabetes-Pre-Diabetes-and-Cardiovascular-Diseases-developed-with-the-EASD
- Guzzo-Merello G, Cobo-Marcos M, Gallego-Delgado M, Garcia-Pavia P. Alcoholic cardiomyopathy. World J Cardiol. 2014; 6: 771–781.
- Anton RF. Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here? Alcohol. 2001; 25: 185–188.
- Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008; 29: 270–276.
- Knott CS, Bell S, Britton A. The stability of baseline-defined categories of alcohol consumption during the adult life-course: a 28-year prospective cohort study. Addiction. 2018; 113: 34–43.
- Rehm J, Roerecke M. Cardiovascular effects of alcohol consumption. Trends in Cardiovasc Med. 2017; 27: 534–538.
- Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014; 12: 182.
- Bergström JP, Helander A. Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: Implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin Chim Acta. 2008; 388: 59–67.
- Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-Ch, Müller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12: 77.
- http://www.biomedcentral.com/1471-2105/12/77/
- Niemelä O. Biomarkers in alcoholism. Clin Chim Acta. 2007; 377: 39–49.
- Golka K, Sondermann R, Reich SE, Wiese A. Carbohydrate-deficient transferrin (CDT) as a biomarker in persons suspected of alcohol abuse. Toxicol Lett. 2004; 151: 235–241.
- Rinck D, Frieling H, Freitag A, Hillemacher T, Bayerlein K, Kornhuber J, Bleich S. Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients. Drug Alcohol Depend. 2007; 89: 60–65.
- Salaspuro M. Carbohydrate-deficient transferrin as compared to other markers of alcoholism: a systematic review. Alcohol. 1999; 19: 261–271.
- Chrostek L, Cylwik B, Szmitkowski M, Korcz W. The diagnostic accuracy of carbohydrate-deficient transferrin, sialic acid and commonly used markers of alcohol abuse during abstinence. Clin Chim Acta. 2006; 364: 167–171.
- Klatsky AL. Alcohol and cardiovascular mortality: common sense and scientific truth. J Am Coll Cardiol. 2010; 55: 1336–1338.
- Xin X., He J., Frontini M.G., Ogden L.G., Motsamai O.I., Whelton P.K.: Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension, 2001; 38: 1112–1117
- Weykamp C, Wielders JPM, Helander A, Anton RF, Bianchi V, Jeppsson JO, Siebelder C, Whitfield JB, Schellenberg F. IFCC Working Group on Standardization of Carbohydrate-Deficient Transferrin (WG-CDT). Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: III. Performance of native serum and serum spiked with disialotransferrin proves that harmonization of CDT assays is possible. Clin Chem Lab Med. 2013; 51: 991–996.
- Bortolotti F, Sorio D, Bertaso A, Tagliaro F. Analytical and diagnostic aspects of carbohydrate deficient transferrin (CDT): A critical review over years 2007–2017. J Pharm Biomed Anal. 2018; 147: 2–12.
- Helander A, Husa A, Jeppsson JO. Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem. 2003; 49: 1881–1890.
DOI: https://doi.org/10.2478/ahem-2023-0010 | Journal eISSN: 1732-2693
Language: English
Page range: 91 - 98
Submitted on: May 25, 2022
Accepted on: Mar 31, 2023
Published on: Oct 4, 2023
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2023 Joanna Dominika Waś, Magdalena Niedolistek, Dorota Sokołowska, Joanna Wiśniewska, Tomasz Zieliński, Anna Mierzyńska, Daniel Rabczenko, Beata Orzechowska, Dominika Franz, Ewa Augustynowicz-Kopeć, Anna Lutyńska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.